ANT308

Overview

ANT308 is a vasoactive intestinal polypeptide ( VIP receptor ) antagonist. ANT308 significantly enhances the activation and proliferation of T cells. ANT308 inhibits the migration and metastasis, induces apoptosis of melanoma tumor cells by inhibiting VIP-VPAC2 signaling and reducing the expression of MCAM and N-cadherin . ANT308 can be used for the studies of acute myeloid leukemia (AML) and uveal melanoma (UVM).

Application

Products | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PACAP Receptor | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-P11288
• CAS No.: 2871680-36-1
• Molecular Formula: C156H261N47O40S
• Molecular Weight: 3467.10
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source